Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/37407
Title: Perioperative risk assessment for successful kidney transplant in leigh syndrome: A case report.
Authors: McMahon L.P.;Lee D.;Ierino F.;Thyagarajan D. ;Ducharlet K.
Institution: (Ducharlet, McMahon, Lee) Department of Renal Medicine, Eastern Health Clinical School, Monash University, Level 2, 5 Arnold Street, Box Hill, Clayton, VIC, Australia (Thyagarajan) Department of Neurosciences, Monash Health, 246 Clayton Road, Clayton, VIC, Australia (Ierino) Department of Nephrology, St Vincent's Hospital Melbourne, 55 Victoria Parade, Fitzroy, VIC, Australia
Issue Date: 12-Feb-2018
Copyright year: 2018
Publisher: BioMed Central Ltd. (E-mail: info@biomedcentral.com)
Place of publication: United Kingdom
Publication information: BMC Nephrology. 19 (1) (no pagination), 2018. Article Number: 23. Date of Publication: 01 Feb 2018.
Journal: BMC Nephrology
Abstract: Background: Leigh syndrome (LS) is a rare neurodegenerative mitochondrial disorder which typically presents in childhood but has a varied clinical course. Renal involvement such as proximal tubulopathy in patients with mitochondrial disorders has been described. However, end stage renal disease (ESRD) is uncommon and literature regarding patients undergoing kidney transplantation is limited. Successful deceased donor renal transplant has not been previously described in a patient with Leigh Syndrome. Case presentation: We report a 21-year-old Han Chinese man who presented with limb weakness and unsteady gait, which progressed rapidly over a period of months until he was wheelchair-bound. He subsequently developed ESRD and was commenced on hemodialysis. Investigations revealed a m.13513G > A mutation with clinical and radiological features consistent with LS. His mitochondrial disease stabilised and he underwent a multidisciplinary assessment for deceased donor kidney transplantation to identify and minimise the LS-associated perioperative risks and potential negative effects of immunosuppressants on his LS. Successful kidney transplantation followed with excellent graft function three and a half years post-transplant and improvement in the patient's physical function. Conclusion(s): This case highlights the importance of careful pre-transplant perioperative risk assessment and post-transplant care in a rare and heterogeneous neurological disease to achieve an ultimately excellent clinical outcome. To our knowledge, this is the first report of successful deceased donor kidney transplant in a patient with known LS.Copyright © 2018 The Author(s).
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1186/s12882-018-0816-6
Link to associated publication: Click here for full text options
PubMed URL: 29390978 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29390978]
ISSN: 1471-2369 (electronic)
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/37407
Type: Article
Subjects: clinical article
delayed graft function
diet therapy
dietetics
disease association
disease exacerbation
disease severity
drug withdrawal
end stage renal disease/su [Surgery]
end stage renal disease/th [Therapy]
fluid therapy
gene mutation
gene sequence
heart ventricle hypertrophy
hemodialysis
human
hyporeflexia
immunosuppressive treatment
intensive care
*kidney graft
kidney transplantation
*Leigh disease/di [Diagnosis]
*Leigh disease/th [Therapy]
limb weakness
limited mobility
maintenance therapy
male
medical history
migration
muscle hypotonia
myoclonus seizure
nuclear magnetic resonance imaging
*risk assessment
seizure/dt [Drug Therapy]
*surgical risk
transthoracic echocardiography
treatment response
unsteady gait
weakness
young adult
basiliximab
carbamazepine/dt [Drug Therapy]
mycophenolate mofetil/ae [Adverse Drug Reaction]
mycophenolate mofetil/cb [Drug Combination]
mycophenolate mofetil/do [Drug Dose]
prednisolone/cb [Drug Combination]
prednisolone/do [Drug Dose]
propofol
suxamethonium
tacrolimus/cb [Drug Combination]
tacrolimus/do [Drug Dose]
Holter monitor
drug dose reduction
pancolitis/di [Diagnosis]
pancolitis/si [Side Effect]
*perioperative period
physical examination
postoperative care
quality of life
radiology
adult
anesthesia induction
article
Australia
brain radiography
cadaver kidney
cardiovascular risk
case report
cerebellum atrophy/di [Diagnosis]
Chinese
dietetics
disease association
disease exacerbation
disease severity
drug dose reduction
drug withdrawal
end stage renal disease / surgery / therapy
fluid therapy
gene mutation
gene sequence
heart ventricle hypertrophy
hemodialysis
human
hyporeflexia
immunosuppressive treatment
intensive care
*kidney graft
kidney transplantation
*Leigh disease / *diagnosis / *therapy
limb weakness
limited mobility
maintenance therapy
male
medical history
migration
muscle hypotonia
myoclonus seizure
nuclear magnetic resonance imaging
pancolitis / diagnosis / side effect
*perioperative period
physical examination
postoperative care
quality of life
radiology
*risk assessment
seizure / drug therapy
*surgical risk
transthoracic echocardiography
treatment response
unsteady gait
weakness
young adult
Australia
brain radiography
anesthesia induction
adult
Article
cadaver kidney
cardiovascular risk
case report
cerebellum atrophy / diagnosis
Chinese
clinical article
delayed graft function
diet therapy
Type of Clinical Study or Trial: Case series or case report
Appears in Collections:Articles

Show full item record

Page view(s)

16
checked on Aug 18, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.